SCHEMBL6710176

SCHEMBL6710176

Cn1c(C(=O)Nc2ccc(Cl)cc2-c2noc(=O)[nH]2)cc2cccc(OCC3CCCCO3)c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 1/20 0.40
RAB9A P51151 4/20 0.38
NPC1 O15118 2/20 0.38
GRM4 Q14833 1/20 0.36
F11 P03951 6/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GALR3 O60755 1/20 0.36
HTT P42858 1/20 0.36
GRIK1 P39086 1/20 0.36
KLKB1 P03952 3/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
MDM2 Q00987 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711633 0.92 ALDH1A1 (0.35) RAB9ANPC1GRM4LMNASMN1; SMN2
SCHEMBL6708861 0.91 XDH (0.39) PTGER1RAB9ANPC1GRIK1MDM2
SCHEMBL6708005 0.91 EGLN1 (0.38) RAB9AGRM4SMN1; SMN2KDM4EALDH1A1
SCHEMBL6710047 0.90 GRIK1 (0.37) PTGER1GRIK1MDM2
SCHEMBL6713869 0.90 GRIK1 (0.38) PTGER1GRIK1MDM2
SCHEMBL6710444 0.88 PTGER1 (0.40) PTGER1RAB9ANPC1GRM4F11
SCHEMBL6707870 0.87 F10 (0.41) F11GRIK1KLKB1
SCHEMBL6710586 0.86 MAPT (0.36) RAB9ANPC1SMN1; SMN2ALDH1A1HTT
SCHEMBL6709189 0.86 GRIK1 (0.39) PTGER1GRM4LMNAGRIK1MAPT
SCHEMBL6708778 0.85 GRIK1 (0.39) F11GRIK1KLKB1MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PTGER1 3857/4885RAB9A 3732/4885NPC1 3891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.